Target intelligence / Profile preview

Major Histocompatibility Complex Class I Molecule (MHC Class I)

Target
MHC Class I
Molecular classification
Cell Surface Receptor, Glycoprotein
01

Overview

Major histocompatibility complex (MHC) class I molecules are cell surface glycoproteins found on all nucleated cells and platelets in vertebrates. Their primary function is to present peptide fragments derived from intracellular proteins to cytotoxic T lymphocytes (CTLs), specifically CD8+ T cells, enabling the immune system to monitor cellular health and detect infected or abnormal cells. They are heterodimers composed of a polymorphic heavy α-chain (with three extracellular domains: α1, α2, and α3) and an invariant light chain called beta-2 microglobulin (β2m). The peptide-binding groove is formed by the α1 and α2 domains; it accommodates peptides typically 8–10 amino acids long. The α3 domain interacts with the CD8 co-receptor on cytotoxic T cells. β2-microglobulin stabilizes the structure but does not span the membrane. MHC class I genes correspond to HLA-A, HLA-B, and HLA-C loci within the human leukocyte antigen (HLA) complex. CTLs recognize foreign or abnormal peptides presented by MHC class I. If a CTL's receptor matches both peptide and MHC allele, it triggers apoptosis in target cells displaying non-self antigens such as viral or tumor-derived proteins. Normal expression of self-MHC class I inhibits natural killer (NK) cell activity; Loss or reduction of surface MHC-I can activate NK-mediated killing.

Other names
MHC-IHLA Class IHuman Leukocyte Antigen Class I
02

Mechanism of action

N/A

03

Biological functions

Antigen presentationImmune surveillanceT cell activationNK cell regulation
04

Disease associations

Viral infectionCancerAutoimmune diseaseTransplant rejection
05

Safety considerations

Graft rejection (transplantation)Cytokine storm (immunotherapy)
06

Biomarkers

HLA-A allele typeHLA-B allele typeHLA-C allele typeMHC Class I expression levels

Beyond the preview

Go deeper on Major Histocompatibility Complex Class I Molecule (MHC Class I).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major Histocompatibility Complex Class I Molecule (MHC Class I).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call